Estrogens and Parkinson Disease: Novel Approach for Neuroprotection

By Sawada Hideyuki   Shimohama Shun  

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 77-80

Humana Press, Inc

Access to resources Recommend Favorite

Gender Differences in Neurological Disease: Role of Estrogens and Cytokines

By  

Endocrine Journal, Vol. 29, Iss. 2, 2006-04 ,pp. : 243-256

Humana Press, Inc

Access to resources Recommend Favorite

Use of Estrogens for the Prevention and Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 1, 2000-01 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain Perfusion in Patients with both Hypertension and Cerebral Hemodynamic Impairment due to Symptomatic Chronic Major Cerebral Artery Steno-Occlusive Disease: A SPECT Study

By  

Cerebrovascular Diseases, Vol. 33, Iss. 4, 2012-03 ,pp. : 354-361

Karger

Access to resources Recommend Favorite

Melatonin and parkinson’s disease

By Mayo Juan   Sainz Rosa   Tan Dun-Xian   Antolín Isaac   Rodríguez Carmen   Reiter Russel  

Endocrine Journal, Vol. 27, Iss. 2, 2005-07 ,pp. : 169-178

Humana Press, Inc

Access to resources Recommend Favorite